State Street’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-790,730
Closed -$2.81M 3888
2016
Q1
$2.81M Buy
+790,730
New +$4.08M ﹤0.01% 2855

Other funds holding ARLZ

State Street's ARLZ Position: Q2 2016 in Review

State Street sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2016, closing a stake of 790,730 shares — an estimated $2.81M sold.

State Street first reported a position in ARLZ in Q1 2016 and held it in 1 quarter. The position peaked at $2.81M in Q1 2016. 95 funds tracked by Wall St. Rank hold ARLZ as of Q2 2016.

  • State Street reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
  • State Street sold 790,730 Aralez Pharmaceuticals Inc. shares in Q2 2016, an estimated $2.81M.
  • State Street first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 1 quarter.
  • State Street's Aralez Pharmaceuticals Inc. position peaked at $2.81M in Q1 2016.
  • 95 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2016.

Based on State Street's 13F filing for Q2 2016, filed 12 Aug 2016.